COSCIENS Biopharma Inc. Comments on Unusual Market Activity

COSCIENS Biopharma Inc. is issuing a press release in response to unusual market activity. The company confirms it is unaware of any material undisclosed information that would explain the recent increase in trading activity and share price. The press release also contains forward-looking statements regarding the company's expectations, potential risks, and factors that could cause actual results to differ materially. These include risks related to insolvency proceedings, the company's technologies and products, market positioning, tariffs, liquidity, and financial resources. Additional risk factors are detailed in the company's SEC filings. COSCIENS is a life science company focused on developing natural, plant-based active ingredients, including Avenanthramides and Beta Glucan, for skincare brands. The company's shares are listed on the TSX and OTCQB.